| Name | (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid |
|---|---|
| Synonyms |
FMOC-L-SER(ALPHA-D-GALNAC(AC)3)-OH
N-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-serine OVN73571 N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-serine FMOC-SERINE(GALNAC(AC)3-ALPHA-D)-OH Fmoc-Ser(GalNAc(Ac)-α-D)-OH Fmoc-Ser(GalNAc(Ac)3-a-D)-OH N-a-FMoc-O-b-(2-acetaMido-2-deoxy-3,4,6-tri-O-acetyl-a-D-galactopyranosyl)-L-serine N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl]-L-serine (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycbonylamino)propanoicaci N-FMOC-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-ALPHA-D-GALACTOPYRANOSYL)-L SERINE Fmoc-Ser(a-D-GalNAc(Ac)3)-OH FMOC-SER(GALNAC(AC)3-ALPHA-D)-OH Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH, 10 mM in DMSO N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-Alpha-D-galactopyranosyl]-L-serine Fmoc-Ser(Ac3AcNH-α-Gal)-OH Novabiochem Fmoc-Ser(α-D-GalNAc(Ac)3)-OH 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranosyl-Fmoc serine FMoc-Ser(2-acetaMido-3,4,6,-tri-O-acetyl- 2-deoxy-α-D-galactopyranosyl)-OH FMoc-Ser-(Ac3AcNH-α-Gal)-OH Fmoc-L-Ser(TnAc4)-OH,N-alpha-(9-fluorenylmethyloxycbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyr 3-{[4,5-BIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]-3-ACETAMIDOOXAN-2-YL]OXY}-2-{[(9H-FLUOREN-9-YLMETHOXY)C N-α-Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-serine N-ALPHA-FMOC-O-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRIO-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-SERINE Fmoc-Ser(α-D-Gal- NHAc(Ac)3)-OH Fmoc-L-Tnser-OH Fmoc-Ser-(Ac3AcNH-|A-Gal)-OH Tn Antigen: Fmoc-Ser(GalNAc(Ac)3-α-D)-OH N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-serine N-alpha-(9-Fluoroenylmethyloxycbonyl)-o-(2-acetamido-2deoxy-3,4,6-tri-o-acetyl-alpha-d-galactopyranosyl)-l-serine N-alpha-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycbonylamino)propanoic acid N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl]-L-serine 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl-Fmoc serine FMOC-SER(AC3ACNH-ALPHA-GAL)-OH Fmoc-Ser[GalNAc(Ac)3-α- D ]-OH Fmoc-Ser(2-acetamido-3,4,6,-tri-O-acetyl-2-deoxy-|A-D-galactopyranosyl)-OH Fmoc-L-Ser(TnAc4)-OH, N-alpha-(9-Fluorenylmethyloxycbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-serine N-ALPHA-FMOC-O-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-SERINE β-L-Altropyranoside,(2S)-2-cboxy-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl2-(acetylamino)-2-deoxy-,3,4,6-triacetate N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-L-serine N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylaMino)-2-deoxy-α-D-galactopyranosyl]-L-serine FMOC-L-SER(TNAC4)-OH Fmoc-Ser(GalNAc(Ac)3-α-D)-OH L-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl] N-ALPHA-(9-FLUORENYLMETHYLOXYCBONYL)-O-(2-ACETAMIDO-2DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-SERINE GALNAC L-SERINE N-ALPHA-(9-FLUORENYLMETHOXYCBONYL)-O-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-SERINE Fmoc-L-Ser(α-D-GalNAc(Ac)3)-OH N-ALPHA-FMOC-O-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-SERINE GalNAc-Ser Fmoc-Ser(Ac3GalNAcα)-OH |
| Description | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is a drug for cancer. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C32H36N2O13 |
|---|---|
| Molecular Weight | 656.63400 |
| Exact Mass | 656.22200 |
| PSA | 202.09000 |
| LogP | 2.43280 |
| Storage condition | -15°C |
| RIDADR | NONH for all modes of transport |
|---|
| Precursor 7 | |
|---|---|
| DownStream 0 | |